Context Therapeutics Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
2001 MARKET STREET, PHILADELPHIA, PA, 19103
Mailing Address
2001 MARKET STREET, PHILADELPHIA, PA, 19103
Phone
267-225-7416
Fiscal Year End
1231
EIN
863738787
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 23, 2026
- Active drug pipeline with three candidates (CTIM-76, CT-95, CT-202) in early development for cancer treatments.
- Strategic partnerships with companies like Integral Molecular, BioAtla, and Lonza Sales for research, development, and manufacturing support.
Material Events
8-K
Legal Issue
March 13, 2026
High Impact
- Enhanced Board Accountability & Shareholder Empowerment
- Alignment with Corporate Governance Best Practices
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.